The results from a randomized controlled trial were compared with a real-world cohort for the safety and efficacy of a biosimilar to treat chemotherapy-induced neutropenia in patients with breast cancer. READ MORE
Although Lynch syndrome is thought to increase the risk of colorectal and/or uterine cancer, certain mutations may confer an increased risk of breast or ovarian cancer.
Overall costs of radiation therapy for early-stage breast cancer do not burden the health care system when analyzed in relation to survival benefit.
Weight loss was associated with a reduced risk for breast cancer among postmenopausal women.
Nearly one in five women with early-stage breast cancer received guideline-discordant treatment, usually with regards to chemotherapy use.